Agilent Q1 Revenues Flat; Lowers Guidance for 2014 | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies reported after the close of the market on Thursday that revenues for the first quarter of its Fiscal Year 2014 were flat year over year while Life Sciences and Diagnostics revenues ticked up 5 percent.

For the three months ended Jan. 31, total revenues of $1.68 billion narrowly missed the consensus Wall Street estimate of $1.69 billion. Orders of $1.68 billion were down 2 percent from $1.71 billion a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.